Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy

Background Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from oxidative damage. We recently found that low G6PD expression co...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Akimichi Morita, Hiroshi Kato, Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Katsuhiro Okuda, Keisuke Yokota, Shinji Kano
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2024-07-01
סדרה:	Journal for ImmunoTherapy of Cancer
גישה מקוונת:	https://jitc.bmj.com/content/12/7/e008441.full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!